Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61,709,822
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
28,195,401
-
Shares change
-
+937,060
-
Total reported value, excl. options
-
$635,735,229
-
Value change
-
+$17,040,139
-
Number of buys
-
34
-
Number of sells
-
-20
-
Price
-
$22.65
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q3 2020
64 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2020.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,195,401 shares
of 61,709,822 outstanding shares and own 46% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5,839,160 shares), FMR LLC (5,316,516 shares), Redmile Group, LLC (3,391,757 shares), EVENTIDE ASSET MANAGEMENT, LLC (2,838,125 shares), CHI Advisors LLC (2,352,291 shares), TRV GP IV, LLC (2,132,867 shares), CITADEL ADVISORS LLC (1,229,433 shares), FARALLON CAPITAL MANAGEMENT LLC (764,262 shares), Cormorant Asset Management, LP (611,409 shares), and HARVARD MANAGEMENT CO INC (562,379 shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.